Skip to main
BLND

Blend Labs (BLND) Stock Forecast & Price Target

Blend Labs (BLND) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Blend Labs is poised for strong growth as its Autopilot product gains widespread adoption and increases revenue in the Blend Platform segment, with impressive utilization and growth prospects highlighted on several podcasts. The current valuation and guidance for the second quarter may appear disappointing, but Blend's potential with Autopilot, agentification efforts, and expansion into other markets justify premium valuation multiples and may help mitigate risks associated with the current concentration in mortgage revenue.

Bears say

Blend Labs is primarily reliant on its Blend Platform segment for revenue, making it highly vulnerable to any disruptions or challenges within this segment. The company's relationship with Haveli Investments, its largest shareholder, raises concerns about potential conflicts of interest and the extent of Haveli's influence on the company's operations. Additionally, while the company's Autopilot product has potential for significant financial benefits, the uncertainty surrounding its implementation and adoption by customers raises questions about its actual impact on the company's financials.

Blend Labs (BLND) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Blend Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Blend Labs (BLND) Forecast

Analysts have given Blend Labs (BLND) a Buy based on their latest research and market trends.

According to 5 analysts, Blend Labs (BLND) has a Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Blend Labs (BLND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.